At Seqirus, Corporate Responsibility is about conducting our business ethically and contributing to the economic, social and environmental well-being of our communities. We believe that behaving responsibly is critical to the sustainability of our company.

  • > 3,000

    employees globally

  • US $149M

    in research and development investment

  • 10%

    real time production capacity donated to WHO for pandemic response

Seqirus Performance - CSR Infographic png
Seqirus CR Performance

We have published our first summary on key aspects of our Corporate Responsibility performance for the 2017/18 year.

Technician in Liverpool

Our Code of Responsible Business Practice reflects our values and guides the way we do business.


Safety & Quality

As a trusted provider of influenza vaccines and other important medicines, Seqirus is committed to the supply of high quality, safe products that protect and improve public health.

Doctor with Patient administering vaccine

Research Practices

At Seqirus, we are committed to carrying out R&D in an ethical and transparent way as well as in accordance with government regulations and industry codes for good practice.

Learn more



We are driven to transform influenza protection around the world through the development of innovative influenza vaccine technologies and pandemic response solutions.

Learn more
Job Opportunities

Join our dedicated and skilled team on the front line of influenza protection.

Learn more

The Seqirus Leadership Team has deep expertise in the business of influenza and a shared commitment to public health

Learn more